Why Is RocketLab Stock Crashing and is it a Generational Buying Opportunity? | RKLB Stock Analysis
Summary
Parkev states that Rocket Lab is currently in a complex transition phase, balancing high-growth potential with significant financial losses. Parkev notes that the development of the Neutron rocket has been delayed to the fourth quarter of 2026, yet the company continues to demonstrate strong commercial momentum. Revenue has surged from approximately $100 million in mid-2022 to nearly $770 million recently, and the company maintains a massive $2.36 billion backlog, representing three to four years of future revenue.
Parkev highlights that financial metrics are showing signs of improvement, with gross profit margins reaching 36%, which outperformed management's projections. However, Parkev remains cautious because the company is still burning cash, evidenced by a negative 29% cash flow from operations to sales ratio. With a cash reserve of $2.4 billion, Parkev believes the company has enough liquidity to reach its upcoming milestones, but emphasizes that the valuation remains a hurdle for new investors.
Mentioned Stocks
Reasoning: Parkev identifies a significant discrepancy between the current market price of approximately $62 and his calculated fair value of $22 per share. Parkev mentions that while the company's fundamentals are improving—including a 36% gross profit margin and a $2.36 billion backlog—the stock's valuation is still too high given the ongoing losses and negative cash flow. Parkev advises that investors should wait for a better price or consider other high-risk, high-reward opportunities that offer better value than Rocket Lab at its current levels.